Skip to main content

Table 1 Comparison of clinical, laboratory and cancer characteristics between groups

From: The effect of anti-cancer and anti-tuberculosis treatments in lung cancer patients with active tuberculosis: a retrospective analysis

variable TB treatment
n (%)
Lung cancer
n (%)
P value
Demographic
 Age, years 62.1 (25.0–80.0) 65.4 (45.0–83.0) 0.151
 Male, n (%) 29 (93.5) 43 (84.3) 0.220
 BMI (kg/m2) 20.8 21.9 0.024
 Smoker, n (%) 20 (64.5) 28 (54.9) 0.398
Laboratory
 Hypoalbuminemia, n (%) 15 (48.4) 12 (23.5) 0.020
 Anemia, n (%) 12 (38.7) 17 (33.3) 0.627
 Liver dysfunction, n (%) 5 (16.1) 8 (15.7) 0.958
 Renal dysfunction, n (%) 7 (22.6) 12 (23.5) 0.923
 ESR elevation, n (%) 12 (48.0) 13 (32.5) 0.218
Cancer
 Tumor burden, n (%) 28 (90.3) 42 (82.4) 0.328
Type
 Non-small cell, n (%) 25 (80.6) 37 (72.5) 0.635
  Adenocarcinoma 10 (32.3) 17 (33.3)  
  Squamous cell 15 (48.3) 19 (37.3)  
  Large cell 0 1 (1.9)  
 Small cell, n (%) 6 (19.4) 14 (27.5)  
Stage
 Not evaluable 6 (19.4) 5 (9.8) 0.269
 I, n (%) 0 (0) 2 (3.9)  
 II, n (%) 2 (6.5) 3 (5.9)  
 III, n (%) 4 (12.9) 15 (29.4)  
 IV, n (%) 19 (61.3) 26 (50.9)  
KPS 84 ± 8 86 ± 9 0.333
  1. Hypoalbuminemia was defined as a serum albumin concentration < 35 g/L. Anemia was defined as a hemoglobin level < 120 g/L in women and < 130 g/L in men. Liver dysfunction was defined as the total bilirubin levels ≥21  μmol/L and/or prothrombin time index < 50% and/or serum alanineaminotransferase > 35u/L and/or serum aspartate aminotransferase > 35 u/L. Renal dysfunction was defined as serum creatinine ≥88 μmol/L. ESR (erythrocyte sedimentation rate) elevation was defined as ESR ≥ 100 mm/h. Tumor burden was defined as tumor was detected by chest computed tomography. KPS Karnofsky performance score